Together with the local R&D ecosystem, our scientists identified immunogenic targets against the coronavirus spike glycoprotein to provide crucial advances towards the development of diagnostic tools and potential vaccine candidate targets.
Lisa Ng, SIgN
Laurent Rénia, ID Labs
Wang Cheng-I, SIgN
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients